Top 50 Health Care VC Funds & Investors in Norway (November 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Investinor
VC Fund
|
10 | Norway, United States, Sweden | Venture - Series Unknown, Series A | Software, Biotechnology, Manufacturing | $2M–$25M |
|
Farvatn Venture
VC Fund
|
9 | Norway, United States, United Kingdom | Seed, Pre-Seed | Software, Artificial Intelligence, Health Care | $120k–$8M |
|
Skyfall Ventures
VC Fund
|
5 | Norway, Denmark, United States | Seed, Pre-Seed, Venture - Series Unknown | Software, Artificial Intelligence, Information Technology | $350k–$6.1M |
|
Stratel
VC Fund
|
5 | Norway, United Arab Emirates | Seed, Pre-Seed | Software, Robotics, Health Care | $320k–$3M |
|
Birk Venture
VC Fund
|
5 | Norway, United Kingdom | Seed, Series A | Biotechnology, Medical, Health Care | $1.2M–$20M |
|
SINTEF Venture AS
VC Fund
|
4 | Norway, United States, United Kingdom | Seed, Venture - Series Unknown | Manufacturing, Information Technology, Software | $160k–$17M |
|
Forbion Capital Partners
VC Fund
|
3 | United States, United Kingdom, The Netherlands | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $16M–$180M |
|
TeleVenture Management
VC Fund
|
3 | Norway, United States | Venture - Series Unknown, Seed | Software, Manufacturing, Biotechnology | $686k–$5.9M |
|
Sarsia Seed Management
VC Fund
|
3 | Norway | Venture - Series Unknown, Seed | Biotechnology, Software, Pharmaceutical | $1.5M–$3.9M |
|
Hadean Ventures
VC Fund
|
3 | Sweden, Norway, Austria | Series A, Series B, Venture - Series Unknown | Biotechnology, Health Care, Medical | $2M–$79M |
|
Arali Ventures
VC Fund
|
3 | India, United States, Norway | Seed, Series A, Pre-Seed | Artificial Intelligence, Software, B2B | $550k–$36M |
|
M Ventures
VC Fund
|
2 | United States, United Kingdom, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $2.4M–$100M |
|
BIF Partners
VC Fund
|
2 | Germany, Israel, Norway | Seed, Convertible Note, Pre-Seed | Health Care, Biotechnology, Therapeutics | $1.3M–$2M |
|
Meneldor
VC Fund
|
2 | Norway, Germany, United Kingdom | Series A, Seed, Debt Financing | Biotechnology, Health Care, Pharmaceutical | $2.2M–$65M |
|
Sandwater
VC Fund
|
2 | Norway, Germany, Finland | Series A, Venture - Series Unknown, Series B | Manufacturing, Medical, AgTech | $4.7M–$35M |
|
Canica
VC Fund
|
2 | Norway, Denmark, Singapore | Series A, Private Equity, Venture - Series Unknown | Biotechnology, Beauty, Retail | $2.1M–$29M |
|
Schibsted Growth
VC Fund
|
2 | Sweden, Norway, France | Venture - Series Unknown, Seed | Internet, Financial Services, E-Commerce | $123k–$7.7M |
|
Sarsia
VC Fund
|
2 | Norway, Sweden, Finland | Seed, Pre-Seed, Venture - Series Unknown | Software, SaaS, Sensor | $625k–$8.8M |
|
Antler
VC Fund
|
2 | United States, Singapore, Australia | Pre-Seed, Seed, Series A | Software, Artificial Intelligence, Information Technology | $100k–$29M |
|
CCAP Investments & Advisory
VC Fund
|
2 | Norway, Austria, Luxembourg | Series A, Series B, Venture - Series Unknown | Finance, Financial Services, FinTech | |
|
Futurum Ventures
VC Fund
|
2 | Norway, Sweden | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Energy | $4M–$5M |
|
EISMEA
VC Fund
|
2 | Spain, Italy, United Kingdom | Grant, Venture - Series Unknown, Seed | Manufacturing, Biotechnology, Software | $53k–$2.6M |
|
Fyrin
VC Fund
|
1 | Norway | Seed | Health Care | |
|
SR One
VC Fund
|
1 | United States, United Kingdom, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $6M–$175M |
|
Silicon Valley AS
VC Fund
|
1 | Norway | Seed, Pre-Seed | Baby, Wellness, Health Care | |
|
Project Sandwater
VC Fund
|
1 | Norway, The Netherlands | Series A | Medical, Consulting, Life Science | $12M–$20M |
|
Swiss Diabetes Venture Fund
VC Fund
|
1 | United States, Norway, Sweden | Series A, Venture - Series Unknown | Health Care, Medical Device, Medical | $6.6M–$25M |
|
PAACS Invest AS
VC Fund
|
1 | Norway | Seed | Consulting, Health Care, Biotechnology | |
|
SHS Capital
VC Fund
|
1 | Germany, Switzerland, France | Venture - Series Unknown, Series B, Series C | Health Care, Medical Device, Medical | $5.3M–$60M |
|
ProVenture
VC Fund
|
1 | Norway, United States, India | Seed, Venture - Series Unknown | Software, Oil and Gas, Information Technology | $754k–$4M |
|
SpareBank 1
VC Fund
|
1 | Norway, Australia | Venture - Series Unknown, Series A | SaaS, Solar, Banking | $1.5M–$1.8M |
|
The Index Project
VC Fund
|
1 | United States, Denmark, Chile | Seed, Series A, Series B | Chemical, Artificial Intelligence, SaaS | $1.1M–$3M |
|
Yabeo
VC Fund
|
1 | Germany, United States, United Kingdom | Series A, Seed, Series B | Software, Financial Services, FinTech | $1.2M–$29M |
|
Nordic Angel Program
VC Fund
|
1 | Norway, Estonia, Finland | Seed, Angel | Apps, Software, Productivity Tools | $70k–$1M |
|
Glastad Invest
VC Fund
|
1 | Norway | Health Care, Biotechnology, Clinical Trials | ||
|
Arctic Investment Group
VC Fund
|
1 | Norway | Seed | Health Care | |
|
Gezina
VC Fund
|
1 | Norway | Health Care, Biotechnology, Clinical Trials | ||
|
Innovations Kapital
VC Fund
|
1 | Sweden, Denmark, United States | Series B, Series C | Biotechnology, Health Care, Software | $5.5M–$30M |
|
Persimmon Hill
VC Fund
|
1 | Norway, United States | Seed | iOS, Gaming, Retail | |
|
p53
VC Fund
|
1 | Norway, Denmark | Series A | Biotechnology, Medical, Life Science | $30M–$81M |
|
Calm/Storm VC
VC Fund
|
1 | United Kingdom, Germany, Austria | Seed, Pre-Seed, Series A | Health Care, Wellness, Software | $538k–$18M |
|
byFounders
VC Fund
|
1 | Denmark, United States, Sweden | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Health Care | $800k–$65M |
|
Inventure
VC Fund
|
1 | Finland, Sweden, United States | Seed, Series A, Series B | Software, Information Technology, Health Care | $549k–$25M |
|
H2O Holding AS
VC Fund
|
1 | Norway | Pre-Seed | Software, Health Care, Life Science | |
|
Sofinnova Partners
VC Fund
|
1 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | |
|
Dynamk Capital
VC Fund
|
1 | United States, Canada, Norway | Series A, Seed, Series B | Biotechnology, Medical, Health Care | |
|
Lekh Corp AS
VC Fund
|
1 | Norway | Pre-Seed | Software, Health Care, Life Science | |
|
Kupa
VC Fund
|
1 | Norway | Seed | Health Care | |
|
Nordic Impact
VC Fund
|
1 | Norway | Seed | Chemical, Life Science, Visual Search | |
|
CoFounder
VC Fund
|
1 | Norway | Seed, Series A | Industrial, Manufacturing, SaaS | $956k–$2.3M |
| Access all 174 VC funds in Norway Health Care startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Investinor invests in Norwegian based, high potential companies that are internationally oriented and in the phases ranging from early growth to expansion. The company has BNOK 4.2 ($500 m) under management and focus on companies within the internet, software, semiconductors, energy, cleantech, marine and life sciences sectors.
Show more...Investment focus
- Industry: Software, Biotechnology, Manufacturing
- Stage:Venture - Series Unknown, Series A
- Geography: Norway, United States, Sweden
Investor stats
- Total investments: 134
- Round size: Series A $2.3M–$25M; Venture - Series Unknown $2M–$19M
- Lead/follow: 51% lead, 49% follow
- Last fund: May invest from a new fund soon — raised $274M in 2011
Portfolio highlights
- Sonair — Sonair is building ADAR, the world's first safety-certified 3D sensor for human-robot collaboration. The commercial product is available now. Reach out for a demo.
- Two — Buy Now, Pay Later for your business customers. Two makes it easy and safe to offer invoice as a payment method on your e-commerce site.
- Muybridge — Muybridge builds real-time, software-defined cameras. Be anywhere: capture, replay and navigate live action from any angle, with zero latency.
Planet 9 Venture supports startups and work with venture funds to make a positive imprint on the world.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Pre-Seed
- Geography: Norway, United States, United Kingdom
Investor stats
- Total investments: 85
- Round size: Seed $1M–$8M; Pre-Seed $120k–$1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Visoid — Render your 3D models with ease! Quick and easy rendering software for architects, powered by AI. Try Visoid for free!
- BioSort — Biometrics provides lice, biomass, extraction, and data analysis. They offer feed, fish health, welfare, optimized harvest aquaculture, and fisheries. They provide sensor technologies, machine vision, AI, software, mechatronics.
- Birdsview — Sensor fusion of GPR radar, lidar and camera plus AI analysis: see inside any concrete structure without breaking it.
We are an early stage venture capital firm based in Oslo, Norway.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Norway, Denmark, United States
Investor stats
- Total investments: 65
- Round size: Seed $1.2M–$6.1M; Pre-Seed $350k–$3.3M; Venture - Series Unknown $1.1M–$1.6M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — raised $29M in 2022
Portfolio highlights
- Visoid — Render your 3D models with ease! Quick and easy rendering software for architects, powered by AI. Try Visoid for free!
- CYBRET AI — Continuous Black, Grey, and White box pentesting. Cover authorized targets, prove exploitable findings with replay evidence, and ship the fix.
- Volve — AI for construction tendering: contract review, quantity take-off, scope review, bid development and offer comparison. Every finding traced to source.
Stratel AS is a family owned Norwegian investment and development company, founded in 1976 by Reidar Lorentzen. Stratel invests in entrepreneurs and companies with high ambitions, positive impact and a promising value potential. We invest in both startups, ventures and mature businesses. Their investment philosophy is for Fun, Sense and Profit.
Show more...Investment focus
- Industry: Software, Robotics, Health Care
- Stage:Seed, Pre-Seed
- Geography: Norway, United Arab Emirates
Investor stats
- Total investments: 11
- Round size: Seed $320k–$3M; Pre-Seed $600k–$2M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Oivi — Smart and automated eye screening, anywhere.
- Over Easy Solar — Prefabricated units with vertical bifacial solar panels for flat and green rooftops. The innovative photovoltaic solution from Over Easy Solar is unique, with quick and easy mounting for sedum roofs and flat roofs with low load-bearing capacity.
- Inherit Carbon Solutions — Permanent carbon removal from organic waste, operational today. We capture biogenic CO2 and store it permanently under the North Sea.
Birk Venture is a Scandinavian venture company exclusively focusing on the life science industry.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Seed, Series A
- Geography: Norway, United Kingdom
Investor stats
- Total investments: 9
- Round size: Seed $1.3M–$15M; Series A $1.2M–$20M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- APIM Therapeutics — APIM Therapeutics is based on an original discovery by Prof. Marit Otterlei and co-inventors at the Department of Cancer Research and Molecular Medicine at NTNU (Trondheim, Norway). The company is currently developing proprietary peptide drugs targeting PCNA (Proliferating Cell Nuclear Antigen), a key DNA repair protein regulating cellularresponses to DNA damage and stress.
- Zelluna Immunotherapy — Zelluna Immunotherapy AS is a privately owned biopharmaceutical company focused on the development of TCR based immunotherapies.
- Accession Therapeutics — Accession Therapeutics is developing novel immuno-oncology therapeutics – combining high specificity and potency to counter tumor diversity. It is the first company to have engineered a viral point of entry to cancer cells while bypassing healthy cells - so it’s ‘gloves off’ in the fight against cancer." It was founded in 2020 and is locatedin Oxford, Oxfordshire, United Kingdom.
We commercialize technology created by SINTEF's research environments
Show more...Investment focus
- Industry: Manufacturing, Information Technology, Software
- Stage:Seed, Venture - Series Unknown
- Geography: Norway, United States, United Kingdom
Investor stats
- Total investments: 34
- Round size: Seed $160k–$6.2M; Venture - Series Unknown $1.5M–$17M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — raised $62M in 2018
Portfolio highlights
- Sonair — Sonair is building ADAR, the world's first safety-certified 3D sensor for human-robot collaboration. The commercial product is available now. Reach out for a demo.
- Hystar — Hystar develops polymer electrolyte membrane electrolyzers designed for large-scale green hydrogen production. Founded in 2020, Hystar's technology uses a unique cell design and process architecture that provides the ability to reduce electricity consumption and increase hydrogen output, enabling professionals to tackle various criticalenergy challenges and having the potential to reduce greenhouse gas emissions.
- Hydrogen Mem-Tech — Hydrogen Mem-Tech aim is to make the green shift happen through our state-of-the-art hydrogen separation technology with carbon capture.
Impacting the future of medicine.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, The Netherlands
Investor stats
- Total investments: 229
- Round size: Series A $20M–$180M; Series B $16M–$155M; Series C $22M–$123M
- Lead/follow: 51% lead, 49% follow
- Last fund: Likely actively investing — fresh fund, raised $606M in 2026
Portfolio highlights
- OMass Therapeutics — OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics against challenging disease targets.
- Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
- Lisata Therapeutics — Lisata is a clinical-stage pharmaceutical company dedicated to improving lives through the discovery, development, and commercialization of innovative medicines.
Making Venture Happen. Televenture is one of the leading venture capital companies in Norway.
Show more...Investment focus
- Industry: Software, Manufacturing, Biotechnology
- Stage:Venture - Series Unknown, Seed
- Geography: Norway, United States
Investor stats
- Total investments: 26
- Round size: Venture - Series Unknown $686k–$5.9M
- Lead/follow: 65% lead, 35% follow
- Last fund: May invest from a new fund soon — last raise in 2014
Portfolio highlights
- CrayoNano — CrayoNano is a next generation semiconductor company. We specialize in nanotechnology that will enable a more sustainable and healthier life for tomorrow.
- Genetic Analysis — Genetic Analysis AS (GA) has the goal of being a leader within the field of molecular diagnostics of diseases related to gut imbalances. By utilizing the DNA-based GA-map™ array technology, profiles of a patient’s gut microbiota is quickly generated and can be related to various health conditions. Genetic Analysis has developed a DNA-basedtechnology platform that allows for simultaneous analysis of a large number of similarities (but not identical) gene fragments in one reaction. The company’s focus is to utilize this technology platform to identify variations in the hundreds of different bacteria that exist in the gut (large and small intestine). The GA - map makes it possible, for the first time, to offer a diagnostic solution – including early detection - for many diseases that are affected by imbalances in the gut microbiota. Genetic Analysis will offer kits and services for a wide range of applications.
- Stingray Marine Solutions — Stingray Marine Solutions is a Norwegian technology firm that produces a laser unit which, when lowered into salmon farming pens, kills sea lice. It is based on entrepreneur Esben Beck’s patented idea in 2010 for salmon louse removal using camera vision and laser. It all started with Esben Beck and a lathe in his basement in 1999. After more than10 years of deliveries to oil, gas and offshore companies, he decided to invest in his own products. He decided to found and develop his own salmon louse project, where design, production, software development, testing, and installation were carried out by using in-house resources.Stingray is based in Oslo, Norway.
Sarsia Seed AS is a Norwegian Seed Capital Fund which invests in Norwegian early phase technology companies within the energy/cleantech and biotechnology/life science sectors. The fund has a total capital of 333.5 million NOK (approx, 40 mEUR/50 mUSD) and is managed by Sarsia Seed Management AS. The management company advises the Fund board regarding investment decisions. The Fundâ€:tm:s duration is expected to be 12 (+3) years. The Management Teamâ€:tm:s strength lay in its competence, experience and extensive national and international network of industrial players and co-investors. The Teamâ€:tm:s collective experience comprises an optimal balance between operations, business and specialised technology know-how, applied research, and entrepreneurship; elements which are actively used both in the vetting and follow-up of investments.
Show more...Investment focus
- Industry: Biotechnology, Software, Pharmaceutical
- Stage:Venture - Series Unknown, Seed
- Geography: Norway
Investor stats
- Total investments: 11
- Round size: Venture - Series Unknown $1.5M–$3.9M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- BerGenBio — BerGenBio is a clinical stage oncology biotech company, which is engaged in developing therapeutics against novel drug targets that drive aggressive cancers. Its drug candidate bemcentinib (BGB324) is in clinical development as a novel treatment for a variety of cancers.
- Sonoclear — At SonoClear, we are dedicated to improving the diagnostic accuracy of ultrasound to give neurosurgeons the clarity needed to make critical decisions in the resection of tumours.
- Heimdall Power — Heimdall Power helps utilities optimize the power grid with state-of-the-art sensors and software, enabling real-time capacity management and situational awareness for a more efficient and reliable energy system.
Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region. The funds are backed by leading private and institutional investors. Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across the region
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: Sweden, Norway, Austria
Investor stats
- Total investments: 36
- Round size: Series A $4.2M–$79M; Series B $4.5M–$75M; Venture - Series Unknown $2M–$29M
- Lead/follow: 50% lead, 50% follow
- Last fund: May invest from a new fund soon — raised $168M in 2021
Portfolio highlights
- Oncoinvent — Oncoinvent AS designs and develops cancer treatments by applying known physical and chemical principles of selected novel materials in new ways in order to maximize their medical benefit while minimizing potential safety concerns.
- Kasvu Therapeutics — Kasvu develops first and best-in-class small molecule neuroplastogens for diseases where neuronal connectivity is altered
- TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!We are a seed fund focused on enterprise tech businesses out of India. We invest early, help build the venture with the promoter teams.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, B2B
- Stage:Seed, Series A, Pre-Seed
- Geography: India, United States, Norway
Investor stats
- Total investments: 43
- Round size: Seed $550k–$3.5M; Pre-Seed $600k–$1.6M; Series A $567k–$36M
- Lead/follow: 58% lead, 42% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Mannjal — Growth platform for regional NBFCs/Lenders
- Flo Mobility — India's largest construction robotics company. Autonomous material movement robots and electric wheelbarrows that cut site costs. No capex.
- RenaissThera — RenaissThera is a biotechnology startup that uses AI platforms to produce low-cost, new small-molecule-targeted medicines.
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by great entrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 190
- Round size: Seed $2.4M–$24M; Series A $5.8M–$56M; Series B $13M–$100M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Mueon — semiconductor-based systems for AI and hyperscale computing
- Nouscom — Nouscom is a next-generation immunotherapy company developing genetic cancer vaccines and oncolytic viruses..
- iOnctura — Our mission is to develop high impact, low disruption therapies that extend healthspan. We do this by disrupting the dynamic interplay at the heart of the
Angel Investors focusing on Seed Investments
Show more...Investment focus
- Industry: Health Care, Biotechnology, Therapeutics
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: Germany, Israel, Norway
Investor stats
- Total investments: 14
- Round size: Seed $1.3M–$2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Hemispherian — Hemispherian is an innovative preclinical pharmaceutical company focused on developing a novel class of small molecule drugs. These drugs target the TET2 enzyme as an epigenetic therapy for particularly aggressive cancers.
- ECO Group — Eco is a supplier of consumer products. They create structures for increased growth and profitability within the group companies.
- Lucid Genomics — Lucid Genomics is an AI-powered platform that focuses on diagnostics and biomarker detection. It offer comprehensive DNA analysis, that includes coding and non-coding mutation prioritization and interpretation.
Meneldor is a Dutch life-sciences investment firm backing exceptional science with disciplined VC capital to build and scale European biopharma with real impact.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series A, Seed, Debt Financing
- Geography: Norway, Germany, United Kingdom
Investor stats
- Total investments: 8
- Round size: Series A $2.2M–$65M; Debt Financing $10M–$10M
- Lead/follow: 88% lead, 12% follow
Portfolio highlights
- Hemispherian — Hemispherian is an innovative preclinical pharmaceutical company focused on developing a novel class of small molecule drugs. These drugs target the TET2 enzyme as an epigenetic therapy for particularly aggressive cancers.
- Atriva Therapeutics — Therapies against viral infections. First-in-class host-targeting therapies to treat respiratory viral infections, including COVID-19 and influenza.
- Tagworks Pharmaceuticals — As pioneers of Click-to-Release technology, we are revolutionizing cancer treatment using in vivo click chemistry to increase the therapeutic window of powerful cancer therapies.
We are Sandwater. Regeneration of our resources. Vitalizing healthcare & education. Improving life through technology.
Show more...Investment focus
- Industry: Manufacturing, Medical, AgTech
- Stage:Series A, Venture - Series Unknown, Series B
- Geography: Norway, Germany, Finland
Investor stats
- Total investments: 24
- Round size: Series A $8.5M–$24M; Series B $17M–$35M; Venture - Series Unknown $4.7M–$18M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Mantle8 — Using bottom-up exploration and decades of geology experience, we are on a mission to deliver natural hydrogen to the world.
- CurifyLabs — CurifyLabs enables 3D printed personalized medicines in pharmacies and hospitals. Always close to the patient.
- Alva Industries — Serving industries from aerospace to marine, we deliver high-performance, sustainable motors to drive a cleaner, more efficient future.
Canica is one of the largest privately owned investment companies in Norway. Our operations are focused on active, long-term ownership, primarily within sectors covering retail, fast moving consumer goods and real estate. Canica can offer core expertise within the fields of business development and finance, as well as capital and network in orderto create value and employment in a long-term perspective.
Show more...Investment focus
- Industry: Biotechnology, Beauty, Retail
- Stage:Series A, Private Equity, Venture - Series Unknown
- Geography: Norway, Denmark, Singapore
Investor stats
- Total investments: 16
- Round size: Series A $2.1M–$25M; Venture - Series Unknown $20M–$29M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Healthily — The path to perfect health starts with self-care and Healthily is here to guide you step by step.
- Cytovation — Cytovation AS is a privately-held biotech company, specialising in dermatological diseases, based in Bergen, Norway.
- Oncoinvent — Oncoinvent AS designs and develops cancer treatments by applying known physical and chemical principles of selected novel materials in new ways in order to maximize their medical benefit while minimizing potential safety concerns.
Schibsted Growth is a part of Schibsted Media Group, that invests in and manages a portfolio of fast growing digital companies. With offices in Oslo, Paris and Stockholm the Schibsted Growth team invests in ambitious digital companies with a plan to change the world. The team can help smart founders and winning teams to establish products or services, scale their business, maximize growth and ultimately to become market leaders. By working alongside entrepreneurs, providing cash funding and leveraging the gathered experience and resources within Schibsted Media Group. (Schibsted Media Group operates on 5 continents, in more than 40 markets and provides services that reach hundreds of millions of people around the world every day, empowering people in their daily life.)
Show more...Investment focus
- Industry: Internet, Financial Services, E-Commerce
- Stage:Venture - Series Unknown, Seed
- Geography: Sweden, Norway, France
Investor stats
- Total investments: 51
- Round size: Seed $123k–$7.1M; Venture - Series Unknown $814k–$7.7M
- Lead/follow: 78% lead, 22% follow
Portfolio highlights
- Bookis — Bookis is the Next-Generation Online Bookstore with Direct Author Compensation, making the sharing of stories and knowledge playfully easy - from all bookshelves, for everyone. We leverage community, technology and innovative distribution to enable radically easier peer-to-peer bookselling, with fair author compensation models. Building theworld's largest network of authors fighting for a more fair book industry worldwide.
- Dintero — Dintero is a fintech startup delivering payment, checkout, CRM, and loyalty solutions. The startup's checkout solution offers popular payment methods like Vipps, Swish, invoice, financing, and card payments. It has built its solution for split payment, so that the payments can be split regardless of the payment method. Dintero's aim isfor an online store to be able to choose exactly the payment methods the store itself wants.
- Campanyon — Campanyon is a provider of an outdoor accommodation booking platform intended for people to find and book their next outdoor adventure by connecting campers with hosts.
Sarsia is an early-stage venture capital investor that invest in science-based technology companies. It was founded in 2006 and is located in Bergen, Hordaland.
Show more...Investment focus
- Industry: Software, SaaS, Sensor
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Norway, Sweden, Finland
Investor stats
- Total investments: 10
- Round size: Seed $2.1M–$2.7M; Pre-Seed $625k–$4.3M; Venture - Series Unknown $3.8M–$8.8M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Cetasol — Maritime monitoring and analytics software for commercial fleets. Full visibility, fuel savings, and compliance support.
- Birdsview — Sensor fusion of GPR radar, lidar and camera plus AI analysis: see inside any concrete structure without breaking it.
- Mitigrate — Mitigrate is building a SaaS platform to predict how physical climate risk will impact property assets in the future. The system provides businesses and asset owners with a cost-effective strategy to mitigate risk. The user gets connected to certified, local adaptation specialists who refine and implement the solution.
Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: United States, Singapore, Australia
Investor stats
- Total investments: 2394
- Round size: Seed $159k–$4.6M; Pre-Seed $100k–$611k; Series A $4.1M–$29M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely actively investing — fresh fund, raised $7.5M in 2026
Portfolio highlights
- Praktiki — Praktiki is the AI platform for medical education: expert-led, case-based 5-minute modules HCPs love, built in hours and measured for behaviour change.
- ReportsAI — ReportsAI is an impact operating system that automates data collection and reporting for NGOs and industry to ensure audit-ready compliance.
- Plouton AI —
CCAP Investments & Advisory is an investment firm.
Show more...Investment focus
- Industry: Finance, Financial Services, FinTech
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: Norway, Austria, Luxembourg
Investor stats
- Total investments: 5
- Lead/follow: 80% lead, 20% follow
Portfolio highlights
- Linxfour - Transforming Equipment Finance — linx4 is an Austrian based financing company with a unique market USP in true Pay-per-Use Financing for industrial equipment, where linx4 takes over up to 75% usage risk.
- Fundcraft — The fundcraft team has created a platform that centralizes, coordinates, and gradually automates all fund activities, including transfer agency, accounting, portfolio and risk management, and compliance, among others.
- Optio Incentives — Optio helps businesses incentivize employees, manage equity, stay compliant, and report costs with our software and advisory
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Futurum Ventures invest in visionary entrepreneurs build and scale tech companies.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Energy
- Stage:Seed, Pre-Seed, Series A
- Geography: Norway, Sweden
Investor stats
- Total investments: 7
- Round size: Seed $4M–$5M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- BioSort — Biometrics provides lice, biomass, extraction, and data analysis. They offer feed, fish health, welfare, optimized harvest aquaculture, and fisheries. They provide sensor technologies, machine vision, AI, software, mechatronics.
- Noteless — Noteless develops an AI-powered platform that converts doctor-patient conversations into structured medical notes. This tool is designed to streamline documentation processes for healthcare professionals, allowing them to focus more on patient care. The platform supports various specialties, including general practitioners, physiotherapists, andpsychologists, and is available in multiple languages such as English, German, Spanish, French, Dutch, Norwegian, and Danish. It ensures data privacy by not storing audio recordings or using patient data for model training, adhering to GDPR compliance. Healthcare providers can integrate the platform into their existing systems, aiming to reduce administrative burdens and enhance workflow efficiency.
- Optio Incentives — Optio helps businesses incentivize employees, manage equity, stay compliant, and report costs with our software and advisory
European Innovation Council and SMEs Executive Agency (EISMEA)
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Software
- Stage:Grant, Venture - Series Unknown, Seed
- Geography: Spain, Italy, United Kingdom
Investor stats
- Total investments: 3596
- Round size: Seed $53k–$800k; Grant $54k–$2M; Venture - Series Unknown $573k–$2.6M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- AGADE — Esoscheletri Agade | Il primo esoscheletro intelligente per lavoratori progettato per ridurre il rischio di disturbi muscolari delle spalle nella movimentazione manuale dei carichi.
- BroadBit Batteries — BroadBit is a technology company developing revolutionary new batteries using novel sodium-based chemistries to power the future green economy.
- Aenitis Technologies — We develop innovative devices for cells therapy processing using Acoustic Radiation Forces.
Fyrin is a network of investors and business developers located in Northern Norway who want to contribute to the financing of growth companies in the country.
Show more...Investment focus
- Industry: Health Care
- Stage:Seed
- Geography: Norway
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- LIFENESS — Lifeness is a platform specialized in the treatment of lifestyle diseases and an entrepreneur from the fitness industry,
SR One Capital Management is a leading trans-Atlantic biotech venture capital firm that partners with top entrepreneurs, scientists and investment partners to seek to build elite biotechnology companies. Our mission is to translate ground-breaking technologies into next generation medicines to benef
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 206
- Round size: Series A $6M–$100M; Series B $15M–$114M; Series C $22M–$175M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely actively investing — fresh fund, raised $237M in 2025
Portfolio highlights
- Dren Bio — Dren Bio is a biotechnology company with a portfolio of attractive projects focused on powerful protein engineering technologies for the depletion of cells, protein aggregates, and other disease-causing agents. It is a holding company business model aimed at creating value with multiple projects as stand-alone assets.
- CalciMedica — CalciMedica is a clinical-stage biopharmaceutical company advancing CRAC channel inhibitors for pulmonary hypertension and acute pancreatitis.
- Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
Silicon Valley AS is an innovative privately funded investor in startups funding. Providing venture capital to the following industries: sustainable technologies, mobility, smart cities, web3.0, blockchain, real estate
Show more...Investment focus
- Industry: Baby, Wellness, Health Care
- Stage:Seed, Pre-Seed
- Geography: Norway
Investor stats
- Total investments: 3
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Norveda AS — Refining and redefining human wellness and care.
- Baby Talk AS — Shaping the future of baby and infant care.
Project Sandwater is a fresh take on venture investments within the Nordics and beyond.
Show more...Investment focus
- Industry: Medical, Consulting, Life Science
- Stage:Series A
- Geography: Norway, The Netherlands
Investor stats
- Total investments: 2
- Round size: Series A $12M–$20M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Delft IMP — Delft IMP (Intensified Materials Production) commercializes nanostructuring of particles using atomic and molecular layer deposition (ALD and MLD), based on the patented and publicized IP and know-how developed within the Product & Process Engineering (PPE) group at Delft University of Technology. Following various feasibility projects betweenindustry and university, Delft IMP was initiated end 2014 to truly commercialize the technology.
- Cytovation — Cytovation AS is a privately-held biotech company, specialising in dermatological diseases, based in Bergen, Norway.
Swiss Diabetes Venture Fund is europe’s first venture fund dedicated to diabetes technology.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series A, Venture - Series Unknown
- Geography: United States, Norway, Sweden
Investor stats
- Total investments: 6
- Round size: Series A $6.6M–$24M; Venture - Series Unknown $7.6M–$25M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Piomic — Non-invasive treatment with minimal staff supervision to produce a durable structural, functional and cosmetic closure of hard-to-heal wounds.
- BOYDSense — BOYDSense specializes in developing non-invasive and affordable tools for measuring critical biomarkers via the exhaled breath. The company provides breath-based metabolomics focuses on the capture, identification, and quantification of volatile organic compound (VOC) biomarker patterns in human breath and using it to diagnose and monitor chronicdiseases.It was founded in 2015 and headquartered in South San Francisco, California.
- Luna Diabetes — Luna Diabetes offers smart insulin delivery for pen users, designed for safe overnight use so you can wake up rested and in control.
PAACS Invest is a privately owned Norwegian investment firm that focuses on active investments in healthcare and technology with a focus on sustainability.
Show more...Investment focus
- Industry: Consulting, Health Care, Biotechnology
- Stage:Seed
- Geography: Norway
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Hemispherian — Hemispherian is an innovative preclinical pharmaceutical company focused on developing a novel class of small molecule drugs. These drugs target the TET2 enzyme as an epigenetic therapy for particularly aggressive cancers.
SHS is an independent private equity company. Their focus is on investments in the MedTech, Life Sciences, Diagnostics, and Digital Health sectors.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Venture - Series Unknown, Series B, Series C
- Geography: Germany, Switzerland, France
Investor stats
- Total investments: 44
- Round size: Series B $5.3M–$60M; Series C $6.6M–$14M; Venture - Series Unknown $6.6M–$21M
- Lead/follow: 57% lead, 43% follow
- Last fund: Likely still investing — raised $273M in 2022
Portfolio highlights
- Arzneimittelwerk Warngau — Unsere Schwerpunkte Karriere bei AMW
- ROTOP — ROTOP is a pharmaceutical company. They manufacture cGMP-compliant radiopharmaceuticals for diagnostics and therapy in the fields of nuclear medicine. They provide API/precursor synthesis, analysis kit development, project management, full regulatory support spect, PET, quality control, and therapy services. Their customers contact throughemail and phone number.
- Salvia BioElectronics — Our mission is to give people with migraine a better life. As a pioneer in the field of medical devices, Salvia BioElectronics is passionately committed to empowering people with migraine to reclaim their lives.
ProVenture invest in young digital technology startups in Norway. ProVenture have three seed funds and more than a billion NOK under management. ProVenture is a member of Norwegian Venture Association (NVCA).
Show more...Investment focus
- Industry: Software, Oil and Gas, Information Technology
- Stage:Seed, Venture - Series Unknown
- Geography: Norway, United States, India
Investor stats
- Total investments: 41
- Round size: Seed $754k–$4M; Venture - Series Unknown $1.6M–$3M
- Lead/follow: 63% lead, 37% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Sonair — Sonair is building ADAR, the world's first safety-certified 3D sensor for human-robot collaboration. The commercial product is available now. Reach out for a demo.
- InfoTiles — InfoTiles provides real-time analytics solutions for Digital Water that span the water value chain, from supply & consumption to wastewater treatment and surveillance of waterways. InfoTiles unlocks data-driven planning, operations and maintenance.InfoTiles simplifies and automates the tedious steps of consolidating data, applying real-timeanalytics and machine learning so water utilities can turn insights into actions and benefit from more efficient, sustainable operations.
- The Human Touch Robotics — Introducing robotics with the lightness of the human touch in realms once thought impossible.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!SpareBank 1 Alliance is the second largest financial institution.
Show more...Investment focus
- Industry: SaaS, Solar, Banking
- Stage:Venture - Series Unknown, Series A
- Geography: Norway, Australia
Investor stats
- Total investments: 6
- Round size: Venture - Series Unknown $1.5M–$1.8M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Skyfri — The most advanced operating platform for solar assets - maximizing production and reducing cost.
- AlumatIQ — AlumatIQ specializes in industrial robotics, automation, and digitalization in the aluminum industry. Their first product is robotic automation of the anode change process, with high accuracy, consistency, and speed. Improves health and safety conditions for operators in pot rooms and reduces emissions of HF and greenhouse gases.
- Vow Green Metals — Vow Green Metals purpose is to hasten the global switch to renewable resources by providing environmentally friendly substitutes for fossil reduction agents in the metallurgical sector.
Design to improve life is about solving real problems, small and large, simple and complex, systemic and emerging and is a life-long pursuit. The Index Project is a call to action. Are you in?
Show more...Investment focus
- Industry: Chemical, Artificial Intelligence, SaaS
- Stage:Seed, Series A, Series B
- Geography: United States, Denmark, Chile
Investor stats
- Total investments: 9
- Round size: Seed $1.5M–$2M; Series A $1.1M–$3M
- Lead/follow: 0% lead, 100% follow
- Last fund: May invest from a new fund soon — last raise in 2016
Portfolio highlights
- Agribuddy — Management of agricultural support application "AGRIBUDDY".
- CanopyLAB — CanopyLAB is an educational technology company located in Hvidovre, Greater Copenhagen, Denmark. We have built an AI-powered social learning platform for corporate training. Through personalization our platform enables all learners to realize their potential in a way that is fast, fun and future-proof. We call it "The Future of Learning-Delivered Today".We work on two verticals:1. The Canopy A social learning platform powered by AI A research-based social learning platform for developing competencies through individualized and adaptive learning experiences. It is designed with an integrated social network structure to enhance collaborative learning and built on strong Nordic learning principles.2. The LAB A learning community with provocative content Join our global learning community for youth. Take free courses, exchange ideas, gain new knowledge and practice competencies offered by 100 + pioneering NGOs in controversial and often neglected topics such as sexuality, sexual & reproductive rights, climate action, health, and the SDGs.CanopyLAB acquired Peruvian publishing startup Yopublico in April 2020.
- Destácame — Destacame is the first behavior-based credit score in Latin America.
We are an early-stage investor that believes in flexible Evergreen funding without the limitations of traditional funds.
Show more...Investment focus
- Industry: Software, Financial Services, FinTech
- Stage:Series A, Seed, Series B
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 46
- Round size: Seed $2M–$5.1M; Series A $5.2M–$21M; Series B $1.2M–$29M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- Yazen — Yazen is a digital healthcare provider that offers tailored weight loss programs, combining medical treatments with lifestyle coaching. The platform connects users with a team of experts, including doctors, dietitians, and personal trainers, to create individualized weight management plans.
- WithLess — Apps multiply, costs grow, admin spirals. We get it. The tools your team needs WithLess time, money, and admin.
- norahealth.ai — Leading 3D motion-tracking API that powers digital MSK, health & wellness applications. Automatize motion assessments and track the adherence of your members with our extensive exercise library.
International training and investment program for business angels
Show more...Investment focus
- Industry: Apps, Software, Productivity Tools
- Stage:Seed, Angel
- Geography: Norway, Estonia, Finland
Investor stats
- Total investments: 5
- Round size: Seed $354k–$1M; Angel $70k–$134k
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- GlucoSet — GlucoSet develops tools for accurate continuous glucose monitoring in Intensive Care Units, to reduce patient mortality and hospital costs.
- Fractory — Custom metal fabrication services | Prototyping, project & volume production | 1-1 engineering support, flexible payment terms, instant quotes & lead times.
- Zelos Team Management — Zelos Team Management is a claim-based signup app for volunteer and on-demand teams. Post shifts and tasks, let people claim what fits, and coordinate in built-in chat. Free for unlimited members.
Glastad Holding is a family-owned company whose roots can be traced back to the shipping industry in the early 20th century. Today, Glastad Holding is a thriving investment company with three subsidiaries: Glastad Farsund - real estate, Mosvolds Rederi - shipping, and Glastad Invest - private equity and listed investments. Glastad Holding aims toexert active and long term ownership.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Clinical Trials
- Geography: Norway
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- SantoSolve — SantoSolve is developing topical analgesic products based on non-radioactive strontium as the active substance. The Development program was initiated based on experimental clinical use of strontium-based products showing evidence of strong local analgesic effects on several localized pain conditions of both nociceptive and neuropatic origin. Nosignificant adverse effects associated with the treatment was reported.The company’s lead product, 2PX, is topically administered, utilizing dermal penetration enhancers for delivery of the active agent to its subdermal site of action. Phase I safety and pharmacology studies showed the active agent to have low systemic bioavailability, and only few and minor adverse effects were observed at the site of administration. In open label Phase II clinical trials, the product has shown strong analgesic effect in both nociceptive and neuropatic pain conditions. In follow up, placebo controlled trials, the analgesic effect of the product has been further documented. In the company’s most advanced pain indication under study, osteoarthritis, the company has recently completed the Phase II program.These trials supports the open label results and document statistically that the analgesic effect in patients treated with 2PX is superior to that observed with placebo treatment.
Vi investerer i nordnorske vekstselskaper med globale ambisjoner!
Show more...Investment focus
- Industry: Health Care
- Stage:Seed
- Geography: Norway
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- LIFENESS — Lifeness is a platform specialized in the treatment of lifestyle diseases and an entrepreneur from the fitness industry,
Gezina
Show more...Investment focus
- Industry: Health Care, Biotechnology, Clinical Trials
- Geography: Norway
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- SantoSolve — SantoSolve is developing topical analgesic products based on non-radioactive strontium as the active substance. The Development program was initiated based on experimental clinical use of strontium-based products showing evidence of strong local analgesic effects on several localized pain conditions of both nociceptive and neuropatic origin. Nosignificant adverse effects associated with the treatment was reported.The company’s lead product, 2PX, is topically administered, utilizing dermal penetration enhancers for delivery of the active agent to its subdermal site of action. Phase I safety and pharmacology studies showed the active agent to have low systemic bioavailability, and only few and minor adverse effects were observed at the site of administration. In open label Phase II clinical trials, the product has shown strong analgesic effect in both nociceptive and neuropatic pain conditions. In follow up, placebo controlled trials, the analgesic effect of the product has been further documented. In the company’s most advanced pain indication under study, osteoarthritis, the company has recently completed the Phase II program.These trials supports the open label results and document statistically that the analgesic effect in patients treated with 2PX is superior to that observed with placebo treatment.
InnovationsKapital was founded in 1994 and is a leading independent venture capital firm for innovative growth companies in the Nordic region. The business, carried out from offices in and Stockholm, Gothenburg and New York, is focused on investments within ICT and Healthcare & Life Sciences, dynamic sectors that are rapidly expanding and whereNordic research plays an important role. The capital is provided by highly reputable Swedish and international institutional investors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series B, Series C
- Geography: Sweden, Denmark, United States
Investor stats
- Total investments: 19
- Round size: Series B $5.6M–$30M; Series C $5.5M–$15M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Silecs — PiBond is an independent European maker of ultra-pure patterning, dielectric and optical materials for semiconductor, photonics and medical device clients.
- SantoSolve — SantoSolve is developing topical analgesic products based on non-radioactive strontium as the active substance. The Development program was initiated based on experimental clinical use of strontium-based products showing evidence of strong local analgesic effects on several localized pain conditions of both nociceptive and neuropatic origin. Nosignificant adverse effects associated with the treatment was reported.The company’s lead product, 2PX, is topically administered, utilizing dermal penetration enhancers for delivery of the active agent to its subdermal site of action. Phase I safety and pharmacology studies showed the active agent to have low systemic bioavailability, and only few and minor adverse effects were observed at the site of administration. In open label Phase II clinical trials, the product has shown strong analgesic effect in both nociceptive and neuropatic pain conditions. In follow up, placebo controlled trials, the analgesic effect of the product has been further documented. In the company’s most advanced pain indication under study, osteoarthritis, the company has recently completed the Phase II program.These trials supports the open label results and document statistically that the analgesic effect in patients treated with 2PX is superior to that observed with placebo treatment.
- Action Pharma — Providing a surprisingly human shopping experience. Trusted and secure. Millions of domains to choose from.
Persimmon Hill
Show more...Investment focus
- Industry: iOS, Gaming, Retail
- Stage:Seed
- Geography: Norway, United States
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- UNISOT™ — UNISOT™ is a Norwegian B2B Supply Chain Sustainability PaaS, enabling global supply chain actors to be more sustainable as well as enabling them to prove it to their customers and consumers. With our 360° Supply Chain connectivity we also enable our customers to produce verifiable ESG/Sustainability reporting as well as verifiable End-to-EndScope 3 (GHG) reporting.Our main focus is to provide solutions to all actors of global supply chains to be more sustainable by being more efficient as well as provide tools that enable them to Prove their product Quality, Provenance and Sustainability; all functions that are becoming mandatory with the new regulations like UN/EU Supply Chain Traceability laws, EU Taxonomy for Sustainability and EPA Scope 1,2,3 https://unisot.com/esg.
- FYX Gaming — Web3 development platform & scaling solutions on the blockchain, proud creator of CryptoFights.
p53 identifies and invests in innovative healthcare companies, particularly in the fields of biotechnology and medical devices.
Show more...Investment focus
- Industry: Biotechnology, Medical, Life Science
- Stage:Series A
- Geography: Norway, Denmark
Investor stats
- Total investments: 2
- Round size: Series A $30M–$81M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Calluna Pharma — Join Calluna Pharma to transform therapeutics for inflammatory and fibrotic diseases. With a robust pipeline, seasoned leadership, and strategic alliances, we can revolutionize patient care.
- Teitur Trophics — Teitur Trophics is a biotech company developing circular peptides for neurodegenerative diseases. The company was founded in 2020 and is headquartered in Aarhus, Denmark.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Calm/Storm is an exclusive founder network and venture capital firm. We invest in purpose driven founders changing our life & health for the better. Headquartered in Vienna, Austria we invest in early-stage companies all over Europe and the US. We focus on the pre-seed and seed stages but also invest up to Series A.
Show more...Investment focus
- Industry: Health Care, Wellness, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, Germany, Austria
Investor stats
- Total investments: 128
- Round size: Seed $1.1M–$6.5M; Pre-Seed $538k–$2.6M; Series A $7.6M–$18M
- Lead/follow: 7% lead, 93% follow
- Last fund: May invest from a new fund soon — raised $23M in 2020
Portfolio highlights
- Leaders21com — They offer our customers an exciting portfolio of practical training and services. Based on our many years of experience and our specially developed leadership approach. Flexibility and situational action are essential leadership qualities. That is why we also structure our cooperation with our customers in exactly the same way - flexible andadapted to individual requirements. Digital and analog.
- The Joy Club — The Joy Club offers online activities, events, classes, and experiences for elderly people to remove loneliness.
- Bea Fertility — Bea Fertility is a monthly subscription program that provides users with at-home fertility treatment and ovulation tracking.
byFounders is the community-powered early-stage venture fund investing in globally ambitious teams connected to the Nordic and Baltic countries. With its unique Collective of founders and operators, byFounders offers its portfolio operational expertise and a global network. Believing in the power of tech to shape our future, byFounders takes an impact-aware approach to investing and working with the broader startup ecosystem.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: Denmark, United States, Sweden
Investor stats
- Total investments: 114
- Round size: Seed $1.5M–$9.4M; Pre-Seed $800k–$4.2M; Series A $6.1M–$65M
- Lead/follow: 52% lead, 48% follow
- Last fund: May invest from a new fund soon — raised $117M in 2021
Portfolio highlights
- Flare — Flare builds infrastructure for a more internet by connecting real-world data with machine learning in a verifiable way.This combines human intelligence with advanced AI to improve the clarity and reliability of information.Its goal is to create a shared, high-quality knowledge foundation that helps people navigate information with confidence.
- Verda (formerly DataCrunch) — DataCrunch is a cloud service provider which facilitates utilization and integration of state of the art AI/ML models
- Spiral Hydrogen — Spiral Hydrogen's mission is to lower the price of green hydrogen below that of fossil hydrogen, so opening up an industry for decarbonization and making hydrogen transportation and heating commercially viable.
Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A, Series B
- Geography: Finland, Sweden, United States
Investor stats
- Total investments: 172
- Round size: Seed $549k–$5.9M; Series A $1.3M–$17M; Series B $1.3M–$25M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $169M in 2022
Portfolio highlights
- Finch — Optimize building design with AI and graph technology. Get immediate feedback on performance, detect errors and find optimal solutions.
- ONEiO — ONEiO is a cloud-native integration service provider connecting people, processes, and tools – enabling seamless collaboration without traditional integration hassle. Provided as a turn-key solution, as self-service, or something in between. You choose.
- Valuebeat — Grow your culture. Backed by data. Platypus is the HR and recruitment tool that measures cultural drivers of people across the organization to help you qualify decisions on hiring and managing your culture.
Investment
Show more...Investment focus
- Industry: Software, Health Care, Life Science
- Stage:Pre-Seed
- Geography: Norway
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Aurora Analytica — AI-powered clinical intelligence for CROs. Country strategy, feasibility simulation, and trial intelligence in one platform. ESMO-published. EIC-selected. Norway.
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 288
- Lead/follow: no public data
Portfolio highlights
- DNA Script — DNA Script is a disruptive DNA synthesis company engineering biology to accelerate breakthroughs in life science and human health. Their revolutionary enzymatic technology powers the world's first benchtop DNA printer, SYNTAX, enabling labs to print their own synthetic oligos for greater workflow control and faster access to results.
- AAVantgarde Bio — AAVantgarde Bio is developing gene therapies for inherited retinal disorders.
- Excelsior Sciences — Rebuilding the World, From the Bottom Up
Dynamk Capital is a New York headquartered growth equity and venture capital firm investing in life science industrials: tools, technologies and services that are critical for the discovery, development and production of life-saving therapies. Venture capital for Life Science tools.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series A, Seed, Series B
- Geography: United States, Canada, Norway
Investor stats
- Total investments: 20
- Lead/follow: no public data
Portfolio highlights
- CellFE — We transform the way cell therapies are manufactured to enable affordable advanced treatments for all.
- Lucid Scientific — Lucid Scientific is the maker of Resipher - the world's first handheld cell culture monitor to measure real-time oxygen consumption from inside an incubator.
- Vernal Biosciences — Vernal Biosciences is an mRNA manufacturing company that provides high purity mRNA, from concept to clinical trials, on a transactional basis.
Investment Company
Show more...Investment focus
- Industry: Software, Health Care, Life Science
- Stage:Pre-Seed
- Geography: Norway
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Aurora Analytica — Founded in February 2023 and incorporated in January 2024, Aurora Analytica is a pioneering health technology company dedicated to optimizing the clinical trial lifecycle and accelerating the development of new treatment options. Our AI-powered platform provides strategic insights, site intelligence, and data-driven tools that enable biotech andpharmaceutical companies to design faster, smarter trials. A single platform that brings together essential assessments, the Aurora Suite™ consists of eleven interconnected modules that function collaboratively within a comprehensive analytics environment. Built on over 30 years of industry expertise, Aurora Analytica bridges the gap between innovation and execution—reducing costs, improving accuracy, and ultimately helping bring better therapies to patients, faster.
Kupa
Show more...Investment focus
- Industry: Health Care
- Stage:Seed
- Geography: Norway
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- LIFENESS — Lifeness is a platform specialized in the treatment of lifestyle diseases and an entrepreneur from the fitness industry,
Nordic Impact invests in, supports, and builds businesses and funds based around technology. The company's goal is to make impact investing mainstream and mobilize all business and capital towards solving the big problems in the world while making great financial returns.
Show more...Investment focus
- Industry: Chemical, Life Science, Visual Search
- Stage:Seed
- Geography: Norway
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Iris.ai — Powerful Tools for Your Research. We have built a world-leading AI engine for scientific text understanding. Applied to literature reviews, data extraction, post-market surveillance or any other task involving thousands of documents like papers or patents, this engine will make your life a whole lot easier.
CoFounder is a management and investment company for technology companies with great growth potential. They are experienced entrepreneurs and business developers who provide management resources and early-stage capital. They work with spin-offs from both research and industrial environments, as well as standalone entrepreneurial companies.
Show more...Investment focus
- Industry: Industrial, Manufacturing, SaaS
- Stage:Seed, Series A
- Geography: Norway
Investor stats
- Total investments: 10
- Round size: Seed $956k–$2.3M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- AlumatIQ — AlumatIQ specializes in industrial robotics, automation, and digitalization in the aluminum industry. Their first product is robotic automation of the anode change process, with high accuracy, consistency, and speed. Improves health and safety conditions for operators in pot rooms and reduces emissions of HF and greenhouse gases.
- Aviant — Delivering full-stack drone services that enables autonomous and on-demand transport of cargo.
- Receipts — Receipts is a single set of APIs that connects cashier systems and banks, allowing for digital receipts, card identification, and retail value-added services.
Health Care VC funding in Norway at a glance
Stats across 213 deals from 174 investors.
Access all 174 VC funds in Norway Health Care startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Health Care VC Funds in Norway investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 174 VC funds investing in Norway Health Care startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!